secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harmony Biosciences Holdings, Inc. (HRMY)
CIK:        0001802665
Form:       8-K/A
Filed at:   2023-09-14T23:59:59+00:00
Accession:  0001140361-23-043963
Event type: other_material
Sentiment:  neutral
Materiality: 0.12
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harmony Biosciences corrects Zynerba merger agreement filing, removes non-binding disclaimer
--------------------------------------------------------------------------------

- Filed Amendment No. 1 to 8-K to correct Merger Agreement cover page that erroneously stated it was not binding.
- Corrected agreement is identical to August 14 version except for removal of the disclaimer.
- Merger consideration unchanged: $1.1059 per share cash plus one contingent value right per Zynerba share.
- No financial or operational changes; correction is procedural and does not alter the transaction terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802665/000114036123043963/0001140361-23-043963-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802665/000114036123043963/ef20010653_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-043963

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer